Chamomile Anxiety Meta-analysis: What the Evidence Says

Quick Answer

Chamomile Anxiety Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Despite its widespread use, the scientific evidence supporting aromatherapy's efficacy remains limited by methodological shortcomings, most notably, a reliance on subjective outcome measures such as patient satisfaction, psychometric scales, and self-reported assessments. [Moyano Pedro Almeida (2026); evidence level 1]
• Systematic reviews and methodological critiques published in recent years explicitly recommend the adoption of standardized physiological parameters (e.g., heart rate, blood pressure, respiratory rate) and biochemical markers (e.g., cortisol, inflammatory cytokines) as primary endpoints (,,). [Moyano Pedro Almeida (2026); evidence level 1]
• The International Association for the Study of Pain (IASP) defines pain as an unpleasant sensory and emotional experience associated with actual or potential tissue damage. [Cabral Maria Améllia Lopes (2026); evidence level 3]
• This underscores the urgent need for safe and low-risk complementary approaches to alleviate patient suffering. [Cabral Maria Améllia Lopes (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For chamomile anxiety meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Moyano Pedro Almeida (2026). Effects of aromatherapy on objective physiological outcomes in adult ICU patients: a systematic review. DOI: 10.3389/fmed.2026.1807990. PMCID: PMC13272137. PMID: 42318382. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13272137/
• Cabral Maria Améllia Lopes (2026). Effect of aromatherapy with Matricaria chamomilla in pain and anxiety management in hospital settings: A scoping review protocol. DOI: 10.1371/journal.pone.0339953. PMCID: PMC12768350. PMID: 41490312. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12768350/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.